Optic nerve sheath meningioma: current diagnosis and treatment.

by Christopher S Eddleman, James K Liu
Neurosurgical focus ()


Optic nerve sheath meningiomas (ONSMs) are rare tumors of the anterior visual pathway and constitute approximately 2% of all orbital tumors and 1-2% of all meningiomas. Untreated ONSMs almost always lead to progressive visual decline, color blindness, and finally complete loss of vision. Although resection is warranted in cases of widespread ONSM, surgery can lead to significant morbidity. Recently, stereotactic fractionated radiotherapy has shown effectiveness in improving or stabilizing remaining visual function with minimal procedural morbidity in patients with ONSM. The authors review the incidence, histopathological characteristics, clinical presentation, neuroimaging findings, and current treatment modalities for ONSMs, with an emphasis on fractionated stereotactic radiotherapy.

Cite this document (BETA)

Available from Neurosurgical focus
Page 1
Page 2

Readership Statistics

20 Readers on Mendeley
by Discipline
by Academic Status
20% Other Professional
20% Student (Postgraduate)
10% Researcher (at an Academic Institution)
by Country
10% United States
10% Brazil
5% Japan


Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in